News | April 04, 2026
BASF Pharma Solutions announces up to 20% price hike on excipients and APIs
The company said the increase—up to 20%—takes effect immediately, or as current contracts allow
The company said the increase—up to 20%—takes effect immediately, or as current contracts allow
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
The program, which has been active for over a decade, will now expand its reach, focusing on equitable access to education, resources, and community-driven solutions for patients and care partners
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The new assay consolidates screening for four major viral threats into a single workflow
IntraSight Plus enables confident decision-making and better patient care,” Philips said, emphasizing efficiency, simplicity, and precision
TERN-701, a next-generation therapy targeting chronic myeloid leukemia (CML), a form of blood cancer that still presents treatment challenges despite decades of advances
Capital infusion to accelerate Earendil’s R&D platform
The once-weekly treatment targets Type 2 Diabetes Mellitus (T2DM) with demonstrated efficacy and safety
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
Subscribe To Our Newsletter & Stay Updated
